शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ALKEMNSEAlkem Laboratories Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Thu, 1 Jan, 2026 · 12:27 IST

Alkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passed

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.1%Reaction day
₹5470.00
prior close
₹5454.50
announcement price
In-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.4%-0.5% vs market
Pharmaceuticals peers, median of 156sector-0.0%-0.1% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Midcap 150 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.1+0.4-0.5-0.0-0.1
Next day
+2.1+1.4+0.7+0.7+1.4
2d
+1.8+1.3+0.6+0.1+1.7
3d
+3.4+1.0+2.3+0.3+3.1
4d
+5.9+1.5+4.4+0.9+5.0
5d
+5.9-0.4+6.3-0.7+6.5
1w
+7.6-1.5+9.1-2.3+9.9
15d
+5.1-5.7+10.8-6.8+11.9
1m
+0.8-4.6+5.4-6.7+7.5
2m
+2.1-3.6+5.7-8.0+10.1
3m
-4.0-10.8+6.8-13.7+9.7
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alkem Laboratories has received a GST demand order from the Deputy Commissioner, CGST & Central Excise Division – I, Lucknow, for its Uttar Pradesh GSTIN covering FY 2018-19 to FY 2020-21. The order alleges excess availment of Input Tax Credit and demands GST of Rs. 1,08,81,393 along with an equal amount (Rs. 1,08,81,393) as interest and penalty, taking the total potential exposure to around Rs. 21.76 crore. The order was received on 31st December 2025. The company disagrees with the demand and intends to file an appeal. Alkem has stated there is no material impact on its financials, operations, or other activities.

Likely market impact

The demand size is small relative to Alkem's overall scale and the company has flagged no material financial impact, so the short-term effect on the stock is likely limited; however, the appeal process and any future adverse ruling remain a watchpoint for shareholders.